BioSpace News Archive

The Leapfrog Group, an independent national health care watchdog organization, released Safety In Numbers: Hospital Performance on Leapfrog’s Surgical Volume Standard Based on Results of the 2019 Leapfrog Hospital Survey.

Today, Drug Innovation Ventures at Emory (DRIVE), a nonprofit biotechnology company owned by Emory University, launched a GoFundMe charity campaign to help accelerate testing for its antiviral compound that could potentially be used to treat the new coronavirus associated with the outbreak in China and spreading around the globe.

Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, announced today that management will present at the following upcoming investor conferences:

Anatomy, South Florida’s premier health and wellness brand, has tapped Strategy and Marketing veteran David Geller to lead the company’s business, operations and growth strategies as the newly appointed Chief Operating Officer (COO)

Novocure (NASDAQ: NVCR) today reported financial results for the quarter and year ended December 31, 2019, highlighting continued commercial execution, strengthening financial performance and clinical and product development programs intended to unlock future value.

Preclinical study demonstrates the effects of short-term nicotinamide riboside (NR) supplementation in preventing hearing loss in animal models

Today, Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, reported business highlights and financial results for the fourth quarter and full year ended December 31, 2019.

Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, announced today that it will present new data from two studies of Acthar® Gel (repository corticotropin injection) in multiple sclerosis (MS) relapse

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces an update to its financial outlook and raises its 2020 financial guidance.

X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), today announced it will host a conference call and webcast to report its financial results for the fourth quarter and full year ended December 31, 2019 on March 12, 2020 at 8:30 a.m. ET. The conference call can be accessed by dialing (866) 721-765